Stay updated with breaking news from John Koconis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Timber Pharmaceuticals Announces Late-Breaking Presentation at the American Academy of Dermatology 2022 Annual Meeting - read this article along with other careers information, tips and advice on BioSpace
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Timber Pharmaceuticals Receives Decision to Grant Japanese Patent for Lead Asset TMB-001 Timber PharmaceuticalsApril 28, 2021 GMT - Company is evaluating a topical pharmaceutical composition of isotretinoin for the treatment of moderate to severe subtypes of congenital ichthyosis - Basking Ridge, NJ, April 28, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development an...
Press release content from NewMediaWire. The AP news staff was not involved in its creation. Timber Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for Lead Asset TMB-001 Timber PharmaceuticalsDecember 15, 2020 GMT - Formal notice confirms intent to grant patent for pharmaceutical isotretinoin composition - WOODCLIFF LAKE, NJ - ( NewMediaWire ) - December 15, 2020 - Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orp...